We read with interest the article by Mitchell et al 1 and agree that flow-mediated dilation (FMD%) response may be partially explained by shear stress (diastolic shear stress [DSS]) or flow changes. 2 However, this does not necessarily mean that risk factors do not influence the vascular response. Indeed, Megnien et al 3 showed that shear stress reduction provokes different diameter changes in hypercholesterolemic compared with normal subjects. Moreover, experiments performed by our group (M. Laclaustra et al, unpublished data, 2003) on healthy male subjects showed that HDL-cholesterol level was the strongest predictor of FMD% among all lipid variables considered in the study. This finding was actually apparent after controlling by average flow velocity during the first minute of hyperemia (model's R 2 ϭ0.173). Thus FMD% may have a greater sensitivity to detect the effects of risk factor modification than shear stress, as shown in previous articles, including the one incorporating the very first description of the flow-mediated dilation technique. 4 Indeed, in those reports, significant differences among groups were found for FMD% values but not for hyperemic flow values.
Response: Flow-Mediated Dilation: Just a Marker of Local Shear Stress?
We thank Drs. Laclaustra et al, for their careful reading and thoughtful critique of our study. 1 They suggest that attenuation of the association between cardiovascular disease risk factors and flowmediated dilation (FMD), after adjusting for hyperemic shear response, does not necessarily mean that risk factors do not influence the vascular response. They propose that FMD may have a greater sensitivity to detect the effects of risk factor modification than shear stress. We agree with this point, in principle. However, the issue is not whether FMD or flow is better at detecting abnormalities in regional vascular function. The 2 components of the test (FMD and flow or shear response) evaluate 2 related but distinct aspects of regional vascular function (macrovascular and microvascular). Furthermore, the FMD (macrovascular) component is critically dependent on the flow (microvascular) response, which serves as the stimulus to evoke FMD. Therefore a full understanding of FMD requires consideration of variability in the flow response.
Laclaustra et al also raise the issue, discussed in our paper, that relations between FMD and shear may be attributable to their common dependence on diameter. This was the reason for including a model that evaluated absolute diameter change (FMDmm) and adjusted for hyperemic flow velocity. Laclaustra et al indicate that in their unpublished data, FMDmm is only weakly associated with risk factors and that FMDmm is virtually never reported in the literature. Additionally, they note that . Therefore, most of the association between FMD% and hyperemic shear is attributable to the relations between diameter change and flow rather than the common effects of diameter in the denominators of the FMD% and shear stress equations.
The authors have correctly noted that the R 2 values in the footnote for our Table 3 , which are incorrect, differ from those in the text, which are correct. The R 2 values in the footnote for Table 4 were erroneously duplicated in the footnote for Table 3 during typesetting. We appreciate this important feedback and apologize for the confusion.
We enthusiastically concur with Laclaustra et al that additional studies are needed. We reiterate our recommendation that in future studies, the hyperemic flow stimulus should be carefully assessed in a reproducible manner and formally included in statistical analyses of the associated FMD response. Furthermore, correlates of the absolute systolic, diastolic, or mean hyperemic flow response should be considered separately from the brachial FMD response. Approaches that consider both flow and FMD responses should allow for important and novel insights into factors that differentially affect large and small vessel function. 
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